Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.367
-0.001 (-0.27%)
Apr 29, 2026, 10:55 AM EDT - Market open
Jupiter Neurosciences Employees
Jupiter Neurosciences had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
$4,359
Profits / Employee
-$1,728,979
Market Cap
13.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioCardia | 21 |
| IN8bio | 17 |
| Moleculin Biotech | 17 |
| Soligenix | 14 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
| CDT Equity | 4 |
| Kairos Pharma | 4 |
JUNS News
- 15 days ago - Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14 - Newsfile Corp
- 2 months ago - Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago - GlobeNewsWire
- 2 months ago - Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution - GlobeNewsWire
- 3 months ago - Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users - GlobeNewsWire
- 3 months ago - Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference - Accesswire
- 4 months ago - Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 - GlobeNewsWire
- 5 months ago - Jupiter Neurosciences to Participate in NobleCon21 - Newsfile Corp
- 6 months ago - Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing - GlobeNewsWire